Skip to main content

4 Result(s)

within Article Remove this filter Karen M. Lee Remove this filter Quality of Life Research Remove this filter

and

  1. No Access

    Article

    The Problem of Protocol Driven Costs in Pharmacoeconomic Analysis

    The increasing number of economic evaluations of healthcare interventions and of drug therapies in particular has been well documented. Surveys of the quality of studies have demonstrated that standards of con...

    Mr Douglas Coyle, Karen M. Lee in PharmacoEconomics (1998)

  2. No Access

    Article

    Cost Effectiveness of Epoetin-α to Augment Preoperative Autologous Blood Donation in Elective Cardiac Surgery

    Objective: The objective of this study was to assess the cost effectiveness of using epoetin-α (erythropoietin) to augment preoperative autologous donation (PAD) of blood prior to elective cardia...

    Douglas Coyle, Karen M. Lee, Dean A. Fergusson, Andreas Laupacis in PharmacoEconomics (2000)

  3. No Access

    Article

    Cost Effectiveness of Nasal Calcitonin in Postmenopausal Women

    Objective: To assess the cost effectiveness of nasal calcitonin (Miacalcin®) compared with no therapy, alendronate or etidronate in the treatment of postmenopausal women with previous osteoporoti...

    Prof. Douglas Coyle, Ann Cranney, Karen M. Lee, Vivian Welch… in PharmacoEconomics (2001)

  4. No Access

    Article

    The Role of Models Within Economic Analysis

    Economic analysis of healthcare interventions is increasingly reliant on decision models to estimate the long- term costs and benefits of new therapies. Models permit analysts to take short-term clinical data ...

    Douglas Coyle, Karen M. Lee, Bernie J. O’Brien in PharmacoEconomics (2002)